Ipca Laboratories Limited IPCALAB.BO Stock
Ipca Laboratories Limited Price Chart
Ipca Laboratories Limited IPCALAB.BO Financial and Trading Overview
Ipca Laboratories Limited stock price | 1182.65 INR |
Previous Close | 720.7 INR |
Open | 720.7 INR |
Bid | 735.45 INR x 0 |
Ask | 735.9 INR x 0 |
Day's Range | 720.5 - 737.3 INR |
52 Week Range | 670 - 1033.5 INR |
Volume | 19.97K INR |
Avg. Volume | 23.77K INR |
Market Cap | 186.6B INR |
Beta (5Y Monthly) | 0.134931 |
PE Ratio (TTM) | 38.4877 |
EPS (TTM) | 25.78 INR |
Forward Dividend & Yield | 4 (0.55%) |
Ex-Dividend Date | November 22, 2022 |
1y Target Est | 835.8 INR |
IPCALAB.BO Valuation Measures
Enterprise Value | 175.19B INR |
Trailing P/E | 38.4877 |
Forward P/E | 18.512459 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.9883044 |
Price/Book (mrq) | 3.189976 |
Enterprise Value/Revenue | 2.806 |
Enterprise Value/EBITDA | 18.903 |
Trading Information
Ipca Laboratories Limited Stock Price History
Beta (5Y Monthly) | 0.134931 |
52-Week Change | -16.73% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1033.5 INR |
52 Week Low | 670 INR |
50-Day Moving Average | 741.22 INR |
200-Day Moving Average | 833.01 INR |
IPCALAB.BO Share Statistics
Avg. Volume (3 month) | 23.77K INR |
Avg. Daily Volume (10-Days) | 21.86K INR |
Shares Outstanding | 253.7M |
Float | 130.31M |
Short Ratio | N/A |
% Held by Insiders | 46.66% |
% Held by Institutions | 40.68% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | 37.00% |
Payout Ratio | 0.21530001 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 7.54% |
Operating Margin (ttm) | 10.65% |
Gross Margin | 63.06% |
EBITDA Margin | 14.84% |
Management Effectiveness
Return on Assets (ttm) | 5.11% |
Return on Equity (ttm) | 8.34% |
Income Statement
Revenue (ttm) | 62.44B INR |
Revenue Per Share (ttm) | 246.16 INR |
Quarterly Revenue Growth (yoy) | 17.19% |
Gross Profit (ttm) | 40.63B INR |
EBITDA | 9.27B INR |
Net Income Avi to Common (ttm) | 4.71B INR |
Diluted EPS (ttm) | 19.11 |
Quarterly Earnings Growth (yoy) | -41.19% |
Balance Sheet
Total Cash (mrq) | 21.77B INR |
Total Cash Per Share (mrq) | 85.9 INR |
Total Debt (mrq) | 14.81B INR |
Total Debt/Equity (mrq) | 25.04 INR |
Current Ratio (mrq) | 2.874 |
Book Value Per Share (mrq) | 230.566 |
Cash Flow Statement
Operating Cash Flow (ttm) | 8.06B INR |
Levered Free Cash Flow (ttm) | 1.67B INR |
Profile of Ipca Laboratories Limited
Country | India |
State | N/A |
City | Mumbai |
Address | 125, Kandivli Industrial Estate |
ZIP | 400067 |
Phone | 91 22 6210 5000 |
Website | https://www.ipca.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India.
Q&A For Ipca Laboratories Limited Stock
What is a current IPCALAB.BO stock price?
Ipca Laboratories Limited IPCALAB.BO stock price today per share is 1182.65 INR.
How to purchase Ipca Laboratories Limited stock?
You can buy IPCALAB.BO shares on the BSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ipca Laboratories Limited?
The stock symbol or ticker of Ipca Laboratories Limited is IPCALAB.BO.
Which industry does the Ipca Laboratories Limited company belong to?
The Ipca Laboratories Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Ipca Laboratories Limited have in circulation?
The max supply of Ipca Laboratories Limited shares is 253.7M.
What is Ipca Laboratories Limited Price to Earnings Ratio (PE Ratio)?
Ipca Laboratories Limited PE Ratio is 45.87471000 now.
What was Ipca Laboratories Limited earnings per share over the trailing 12 months (TTM)?
Ipca Laboratories Limited EPS is 25.78 INR over the trailing 12 months.
Which sector does the Ipca Laboratories Limited company belong to?
The Ipca Laboratories Limited sector is Healthcare.